Prostate And Other Male Cancers Archives - MPR

Prostate And Other Male Cancers

Long-Term Benefit for Stereotactic Radn in Prostate CA

Overall, 95.5, 91.4, and 85.1% of patients were free from BCR at 7 years in the low-risk, favorable intermediate-risk, and unfavorable intermediate-risk groups, respectively. The corresponding overall survival rates were 91.4, 93.7, and 86.5%, respectively.